Published in Health Aff (Millwood) on February 01, 2011
PRogram In Support of Moms (PRISM): A Pilot Study (PRISM-Pilot) | NCT02935504
TRIPPD: a practice-based network effectiveness study of postpartum depression screening and management. Ann Fam Med (2012) 2.54
A critical review of methods to evaluate the impact of FDA regulatory actions. Pharmacoepidemiol Drug Saf (2013) 2.00
There are no randomized controlled trials that support the United States Preventive Services Task Force Guideline on screening for depression in primary care: a systematic review. BMC Med (2014) 0.99
Postpartum Depression: Screening, Diagnosis, and Management Programs 2000 through 2010. Depress Res Treat (2012) 0.95
Enhancing Participation in Depression Care in Outpatient Perinatal Care Settings: A Systematic Review. Obstet Gynecol (2015) 0.84
Perinatal depression: a review of US legislation and law. Arch Womens Ment Health (2013) 0.80
Repeated depression screening during the first postpartum year. Ann Fam Med (2015) 0.80
Can Postpartum Depression Be Managed in Pediatric Primary Care? J Womens Health (Larchmt) (2015) 0.79
Perinatal depression screening and intervention: enhancing health provider involvement. J Womens Health (Larchmt) (2012) 0.78
Barriers in the diagnosis and treatment of depression in women in the USA: where are we now? Neuropsychiatry (London) (2013) 0.75
Recent Advances and Controversies in Peripartum Depression. Curr Obstet Gynecol Rep (2016) 0.75
The Mental Health Parity and Addiction Equity Act Evaluation Study: Impact on Specialty Behavioral Health Care Utilization and Spending Among Carve-In Enrollees. Med Care (2016) 0.75
Maternal Deaths From Suicide and Overdose in Colorado, 2004-2012. Obstet Gynecol (2016) 0.75
The Mental Health Parity and Addiction Equity Act evaluation study: Impact on specialty behavioral health utilization and expenditures among "carve-out" enrollees. J Health Econ (2016) 0.75
Should postpartum depression screening policies be reevaluated? Health Aff (Millwood) (2011) 0.75
Screening for and Treating Postpartum Depression and Psychosis: A Cost-Effectiveness Analysis. Matern Child Health J (2016) 0.75
Detection of postnatal depression. Development of the 10-item Edinburgh Postnatal Depression Scale. Br J Psychiatry (1987) 32.05
Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet (1997) 25.40
Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther (2002) 13.95
Perinatal depression: a systematic review of prevalence and incidence. Obstet Gynecol (2005) 8.67
Educational and organizational interventions to improve the management of depression in primary care: a systematic review. JAMA (2003) 6.72
Perinatal depression: prevalence, screening accuracy, and screening outcomes. Evid Rep Technol Assess (Summ) (2005) 6.10
Practice guideline for the treatment of patients with major depressive disorder (revision). American Psychiatric Association. Am J Psychiatry (2000) 5.38
Treating depression in predominantly low-income young minority women: a randomized controlled trial. JAMA (2003) 5.28
Epidemiology of women and depression. J Affect Disord (2003) 5.28
Predictors of postpartum depression: an update. Nurs Res (2001) 4.76
Antenatal risk factors for postpartum depression: a synthesis of recent literature. Gen Hosp Psychiatry (2004) 4.52
The impact of postnatal depression and associated adversity on early mother-infant interactions and later infant outcome. Child Dev (1996) 4.10
Impact of maternal postnatal depression on cognitive development of young children. Br Med J (Clin Res Ed) (1986) 3.48
Effects of redesigned community postnatal care on womens' health 4 months after birth: a cluster randomised controlled trial. Lancet (2002) 3.09
Depression prevalence and incidence among inner-city pregnant and postpartum women. J Consult Clin Psychol (1995) 3.00
Clinical practice. Postpartum depression. N Engl J Med (2002) 2.75
Postpartum depression help-seeking barriers and maternal treatment preferences: a qualitative systematic review. Birth (2006) 2.58
Preconception and interconception health status of women who recently gave birth to a live-born infant--Pregnancy Risk Assessment Monitoring System (PRAMS), United States, 26 reporting areas, 2004. MMWR Surveill Summ (2007) 2.23
Women's attitudes, preferences, and perceived barriers to treatment for perinatal depression. Birth (2009) 1.74
Trends in Medicaid physician fees, 2003-2008. Health Aff (Millwood) (2009) 1.70
The impact of maternal psychiatric illness on infant development. J Clin Psychiatry (1998) 1.69
The relationship between post-natal depression and mother-child interaction. Br J Psychiatry (1991) 1.69
Prevalence, stability, and socio-demographic correlates of depressive symptoms in Black mothers during the first 18 months postpartum. Matern Child Health J (2003) 1.56
Postpartum depression screening: importance, methods, barriers, and recommendations for practice. J Am Board Fam Med (2007) 1.48
Prevalence of self-reported postpartum depressive symptoms--17 states, 2004-2005. MMWR Morb Mortal Wkly Rep (2008) 1.47
Stress, psychosocial resources, and depressive symptomatology during pregnancy in low-income, inner-city women. Health Psychol (2000) 1.44
Reliability of Medicaid claims files for use in psychiatric diagnoses and service delivery. Adm Policy Ment Health (2000) 1.43
Identifying physician-recognized depression from administrative data: consequences for quality measurement. Health Serv Res (2003) 1.42
The onset of postpartum depression: Implications for clinical screening in obstetrical and primary care. Am J Obstet Gynecol (2005) 1.41
What new knowledge would help policymakers better balance investments for optimal health outcomes? Health Serv Res (2003) 1.41
Do reimbursement delays discourage Medicaid participation by physicians? Health Aff (Millwood) (2008) 1.40
Depression screening of perinatal women: an evaluation of the healthy start depression initiative. Psychiatr Serv (2009) 1.37
Routine screening for postpartum depression. J Fam Pract (2001) 1.28
The unhealthy state of health policy research. Health Aff (Millwood) (2009) 1.26
Identifying depression in the first postpartum year: guidelines for office-based screening and referral. J Affect Disord (2004) 1.17
Patient perspectives on improving the depression referral processes in obstetrics settings: a qualitative study. Gen Hosp Psychiatry (2009) 1.16
Postpartum depression: a comparison of screening and routine clinical evaluation. Am J Obstet Gynecol (2000) 1.16
Mental health of children of low-income depressed mothers: influences of parenting, family environment, and raters. Psychiatr Serv (2009) 1.10
The impact of parity on major depression treatment quality in the Federal Employees' Health Benefits Program after parity implementation. Med Care (2006) 1.09
A follow-up study of post partum illness, 1946-1978. Acta Psychiatr Scand (1985) 0.96
The experience of becoming a mother for single, unpartnered, Medicaid-eligible, first-time mothers. J Nurs Scholarsh (2004) 0.86
Systematic review: the relationship between clinical experience and quality of health care. Ann Intern Med (2005) 12.70
Health care costs in the last week of life: associations with end-of-life conversations. Arch Intern Med (2009) 6.46
Cost-related medication nonadherence and spending on basic needs following implementation of Medicare Part D. JAMA (2008) 4.74
Effect of nonpayment for preventable infections in U.S. hospitals. N Engl J Med (2012) 4.19
Outcomes of reference pricing for angiotensin-converting-enzyme inhibitors. N Engl J Med (2002) 4.07
Cost-related medication nonadherence among elderly and disabled medicare beneficiaries: a national survey 1 year before the medicare drug benefit. Arch Intern Med (2006) 3.96
Behavioral health insurance parity for federal employees. N Engl J Med (2006) 3.77
Cost sharing and adherence to tyrosine kinase inhibitors for patients with chronic myeloid leukemia. J Clin Oncol (2013) 3.70
Physician factors associated with discussions about end-of-life care. Cancer (2010) 3.54
Patients at-risk for cost-related medication nonadherence: a review of the literature. J Gen Intern Med (2007) 3.34
Emergency department use and subsequent hospitalizations among members of a high-deductible health plan. JAMA (2007) 3.30
Effect of pay for performance on the management and outcomes of hypertension in the United Kingdom: interrupted time series study. BMJ (2011) 3.29
Cancer screening before and after switching to a high-deductible health plan. Ann Intern Med (2008) 2.80
Impact of adverse events on prescribing warfarin in patients with atrial fibrillation: matched pair analysis. BMJ (2006) 2.71
Cesarean delivery rates vary tenfold among US hospitals; reducing variation may address quality and cost issues. Health Aff (Millwood) (2013) 2.66
Potential bias of instrumental variable analyses for observational comparative effectiveness research. Ann Intern Med (2014) 2.63
Costs and consequences of direct-to-consumer advertising for clopidogrel in Medicaid. Arch Intern Med (2009) 2.54
Advancing the science of patient safety. Ann Intern Med (2011) 2.45
Effects of a law against early postpartum discharge on newborn follow-up, adverse events, and HMO expenditures. N Engl J Med (2002) 2.41
Effect of increased cost-sharing on oral hypoglycemic use in five managed care organizations: how much is too much? Med Care (2005) 2.33
Do newer prescription drugs pay for themselves? A reassessment of the evidence. Health Aff (Millwood) (2007) 2.27
Effect of New York State regulatory action on benzodiazepine prescribing and hip fracture rates. Ann Intern Med (2007) 2.27
Relationship between patient medication adherence and subsequent clinical inertia in type 2 diabetes glycemic management. Diabetes Care (2007) 2.22
Failure of automated telephone outreach with speech recognition to improve colorectal cancer screening: a randomized controlled trial. Arch Intern Med (2010) 2.21
Moving beyond parity--mental health and addiction care under the ACA. N Engl J Med (2011) 2.20
Elevated rates of diabetes in Pacific Islanders and Asian subgroups: The Diabetes Study of Northern California (DISTANCE). Diabetes Care (2012) 2.20
Cost-related medication nonadherence in older patients with rheumatoid arthritis. J Rheumatol (2013) 2.17
How to design computerized alerts to safe prescribing practices. Jt Comm J Qual Saf (2004) 2.11
Methods for estimating confidence intervals in interrupted time series analyses of health interventions. J Clin Epidemiol (2008) 2.09
End-of-life care discussions among patients with advanced cancer: a cohort study. Ann Intern Med (2012) 2.08
Effect of illicit direct to consumer advertising on use of etanercept, mometasone, and tegaserod in Canada: controlled longitudinal study. BMJ (2008) 2.01
A critical review of methods to evaluate the impact of FDA regulatory actions. Pharmacoepidemiol Drug Saf (2013) 2.00
Association between the Part D coverage gap and adverse health outcomes. J Am Geriatr Soc (2012) 1.99
Impact of reference-based pricing for angiotensin-converting enzyme inhibitors on drug utilization. CMAJ (2002) 1.99
Associations between end-of-life discussion characteristics and care received near death: a prospective cohort study. J Clin Oncol (2012) 1.95
The impact of prescribing safety alerts for elderly persons in an electronic medical record: an interrupted time series evaluation. Arch Intern Med (2006) 1.91
Impact of FDA drug risk communications on health care utilization and health behaviors: a systematic review. Med Care (2012) 1.91
The top patient safety strategies that can be encouraged for adoption now. Ann Intern Med (2013) 1.87
Benzodiazepine use and hip fractures in the elderly: who is at greatest risk? Arch Intern Med (2004) 1.86
Medicare part D's exclusion of benzodiazepines and fracture risk in nursing homes. Arch Intern Med (2010) 1.86
FDA drug prescribing warnings: is the black box half empty or half full? Pharmacoepidemiol Drug Saf (2006) 1.83
Physical and mental health status of older long-term cancer survivors. J Am Geriatr Soc (2005) 1.82
Medicare Part D and nursing home residents. J Am Geriatr Soc (2007) 1.74
Unintended impacts of a Medicaid prior authorization policy on access to medications for bipolar illness. Med Care (2010) 1.74
Nearly half of families in high-deductible health plans whose members have chronic conditions face substantial financial burden. Health Aff (Millwood) (2011) 1.71
A political history of federal mental health and addiction insurance parity. Milbank Q (2010) 1.70
Reducing warfarin medication interactions: an interrupted time series evaluation. Arch Intern Med (2006) 1.67
Medicaid prior authorization and controlled-release oxycodone. Med Care (2008) 1.61
Effect of switching antipsychotics on antiparkinsonian medication use in schizophrenia: population-based study. Br J Psychiatry (2005) 1.60
Impact of insurance and supply of health professionals on coverage of treatment for hypertension in Mexico: population based study. BMJ (2007) 1.60
Racial differences in impact of coverage on diabetes self-monitoring in a health maintenance organization. Med Care (2006) 1.56
Impact of a 16-community trial to promote judicious antibiotic use in Massachusetts. Pediatrics (2008) 1.55
Does exposure to conflict of interest policies in psychiatry residency affect antidepressant prescribing? Med Care (2013) 1.55
Medication adherence and racial differences in A1C control. Diabetes Care (2008) 1.53
Synergy between publication and promotion: comparing adoption of new evidence in Canada and the United States. Am J Med (2003) 1.50
Clinical and economic consequences of reference pricing for dihydropyridine calcium channel blockers. Clin Pharmacol Ther (2003) 1.49
Intended and unintended consequences of the gabapentin off-label marketing lawsuit among patients with bipolar disorder. J Clin Psychiatry (2012) 1.48
Cost-related medication nonadherence after implementation of Medicare Part D, 2006-2007. JAMA (2009) 1.48
Net health plan savings from reference pricing for angiotensin-converting enzyme inhibitors in elderly British Columbia residents. Med Care (2004) 1.47
Changing medication use in managed care: a critical review of the available evidence. Am J Manag Care (2003) 1.46
The rise and fall of gabapentin for bipolar disorder: a case study on off-label pharmaceutical diffusion. Med Care (2010) 1.45
The exclusion of benzodiazepine coverage in medicare: simple steps for avoiding a public health crisis. Psychiatr Serv (2005) 1.43
Did Medicare Part D Affect National Trends in Health Outcomes or Hospitalizations? A Time-Series Analysis. Ann Intern Med (2015) 1.42
Interventions designed to improve the quality and efficiency of medication use in managed care: a critical review of the literature - 2001-2007. BMC Health Serv Res (2008) 1.42
Warfarin prescribing in atrial fibrillation: the impact of physician, patient, and hospital characteristics. Am J Med (2006) 1.40
Use of atypical antipsychotic drugs for schizophrenia in Maine Medicaid following a policy change. Health Aff (Millwood) (2008) 1.40
Computerized prescribing alerts and group academic detailing to reduce the use of potentially inappropriate medications in older people. J Am Geriatr Soc (2006) 1.40
A longitudinal study of medication nonadherence and hospitalization risk in schizophrenia. J Clin Psychiatry (2008) 1.39
Aligning incentives in the treatment of depression in primary care with evidence-based practice. Psychiatr Serv (2003) 1.39
Improved therapeutic monitoring with several interventions: a randomized trial. Arch Intern Med (2006) 1.37
Implementation of Medicare Part D and nondrug medical spending for elderly adults with limited prior drug coverage. JAMA (2011) 1.36
Health literacy and antidepressant medication adherence among adults with diabetes: the diabetes study of Northern California (DISTANCE). J Gen Intern Med (2013) 1.36
Whom do older adults trust most to provide information about prescription drugs? Am J Geriatr Pharmacother (2009) 1.36
The effects of mental health parity on spending and utilization for bipolar, major depression, and adjustment disorders. Am J Psychiatry (2013) 1.34
Impact of full mental health and substance abuse parity for children in the Federal Employees Health Benefits Program. Pediatrics (2007) 1.33
Racial differences in long-term adherence to oral antidiabetic drug therapy: a longitudinal cohort study. BMC Health Serv Res (2009) 1.33
Antipsychotic and benzodiazepine use among nursing home residents: findings from the 2004 National Nursing Home Survey. Am J Geriatr Psychiatry (2010) 1.32
A multisite randomized trial of the effects of physician education and organizational change in chronic-asthma care: health outcomes of the Pediatric Asthma Care Patient Outcomes Research Team II Study. Arch Pediatr Adolesc Med (2004) 1.30
Strategies for coping in a complex world: adherence behavior among older adults with chronic illness. J Gen Intern Med (2007) 1.28
Group versus individual academic detailing to improve the use of antihypertensive medications in primary care: a cluster-randomized controlled trial. Am J Med (2005) 1.28
Changes in drug utilization during a gap in insurance coverage: an examination of the medicare Part D coverage gap. PLoS Med (2011) 1.26
The unhealthy state of health policy research. Health Aff (Millwood) (2009) 1.26
A controlled study of the effects of state surveillance on indicators of problematic and non-problematic benzodiazepine use in a Medicaid population. Int J Psychiatry Med (2004) 1.24
Prior authorization for antidepressants in Medicaid: effects among disabled dual enrollees. Arch Intern Med (2009) 1.23
Potentially inappropriate medication use by elderly persons in U.S. Health Maintenance Organizations, 2000-2001. J Am Geriatr Soc (2005) 1.22
Medicare part D and changes in prescription drug use and cost burden: national estimates for the Medicare population, 2000 to 2007. Med Care (2011) 1.21
How the new medicare drug benefit could affect vulnerable populations. Health Aff (Millwood) (2006) 1.21